Established in 2014, 4P-Pharma is a clinical-stage biotech company dedicated to addressing serious diseases with significant unmet medical needs. Our goal is to bring first-in-class therapies to patients swiftly. Our core is a specialized R&D engine that enhances risk management and accelerates the development process, effectively cutting down on time, costs, and uncertainty. We focus on developing assets combining rapid time to market and solid intellectual property. Our strategy leverages cutting-edge clinical trial designs and expedited regulatory pathways to bring our therapies to those in need as quickly as possible.
| Website | https://4p-pharma.com |
| Revenue | $14.9 million |
| Employees | 29 (23 on RocketReach) |
| Founded | 2014 |
| Address | 1 Rue Du Professeur Calmette, Lille, Wallis and Futuna 59000, FR |
| Phone | +33 9 50 72 97 68 |
| Industry | Biotechnology Research, Manufacturing General, Manufacturing |
| Keywords | Treatment, Biotechnology, Clinical Stage, Drug Development, Pharmaceutical Research, Therapeutics, Biopharma, R&D, Unmet Medical Needs, Novel Therapies, Pipeline, First In Class, Serious Diseases, Patient Care, Clinical Trials, Drug Discovery, Healthcare, Life Sciences |
| Competitors | Roche, Pfizer, Boehringer Ingelheim, Bristol Myers Squibb, Novartis, Gilead Sciences, AbbVie, Johnson & Johnson, Sanofi, Merck AH +45 more (view full list) |
| SIC | SIC Code 2834 Companies, SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 33 Companies, NAICS Code 325 Companies |
Looking for a particular 4P-Pharma employee's phone or email?
The 4P-Pharma annual revenue was $14.9 million in 2026.
Revital Rattenbach is the CEO of 4P-Pharma.
23 people are employed at 4P-Pharma.
4P-Pharma is based in Lille, Wallis and Futuna.
The NAICS codes for 4P-Pharma are [3254, 32, 33, 325].
The SIC codes for 4P-Pharma are [2834, 28, 283].